Episode 480: MSToronto 2026 with Dr. Jeffrey Cohen and Dr. Robert Fox

Our coverage of MSToronto 2026 continues this week with two important conversations. First, we'll hear from Dr. Jeffrey Cohen about the latest clinical findings on CAR-T cell therapy as a potential treatment for MS. Then, Dr. Robert Fox will update us on the global research portfolio being driven by the International Progressive MS Alliance.

And we have to talk about Christina Applegate. By now, the news of her misdiagnosis isn't really news. But we have some suggestions for how you might want to process that news.

We have a lot to talk about. Are you ready for RealTalk MS??!

This Week:  MSToronto 2026  :22

But, first, we have to talk about Christina Applegate  :46

Dr. Jeffrey Cohen discusses what the experts are learning about  CAR-T cell therapy   6:51

Dr. Robert Fox shares an update on the global work being driven by the International Progressive MS Alliance  19:03

Share this episode  34:21

Have you downloaded the RealTalk MS app?  34:40

Next week  35:25

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/480